Let’s Talk About Adc Therapeutics SA (NYSE: ADCT)’s Outlook
In the last trading session, 2.21 million Adc Therapeutics SA (NYSE:ADCT) shares changed hands as the company’s beta touched 1.92. With the company’s per share
In the last trading session, 2.21 million Adc Therapeutics SA (NYSE:ADCT) shares changed hands as the company’s beta touched 1.92. With the company’s per share
In last trading session, Adc Therapeutics SA (NYSE:ADCT) saw 1.08 million shares changing hands with its beta currently measuring 1.94. Company’s recent per share price
Adc Therapeutics SA (NYSE:ADCT) has a beta value of -54.37% and has seen 563.71 shares traded in the last trading session. The company, currently valued
Adc Therapeutics SA (NYSE:ADCT)’s traded shares stood at 0.83 million during the last session, with the company’s beta value hitting 1.97. At the close of
Adc Therapeutics SA (NYSE:ADCT) has a beta value of 1.97 and has seen 1.69 million shares traded in the last trading session. The company, currently
During the last session, Adc Therapeutics SA (NYSE:ADCT)’s traded shares were 1.14 million, with the beta value of the company hitting 1.82. At the end
© 2024, Powered by Smart TechOne